ScripAllarity Therapeutics A/S ’s drug response predictor (DRP) technology when used with the chemotherapy Ixempra has shown early promise in a Phase II metastatic breast cancer trial, thrusting the compan
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bone Links With Two Chinese Firms For A
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Novartis Takes Option On Nov
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . BI, Epizyme See Helicase, HA